ADO and cutaneous leishmaniasis: Understanding the molecular mechanisms induced by salivary components such as ADO and AMP—which lead to suppression of effector responses against pathogens—will help not only to understand disease pathogenesis but also to develop new vaccine strategies for cutaneous leishmaniasis.